IntegriChain helps Pharma manufacturers bring their science to market, ensuring patients have affordable, timely, and sustainable access to therapy. We are doing this by building Pharma’s data-driven commercialization platform – from strategy to operational execution. Our unique focus on data, technology, consulting, and outsourcing helps connect the commercial, financial, and operational dimensions of drug access and profitability. IntegriChain enables pharmaceutical innovators to achieve better commercial outcomes by digitalizing daily and recurring business activities and by integrating data and operations across contracting, pricing, channel and distribution, and gross-to-net. We are backed by Nordic Capital, a leading sector-specialized private equity investor with a broad portfolio in Healthcare and Pharma. Additional companies in the IntegriChain family are Blue Fin Group, a leading strategy consultancy for the Pharma industry, and Federal Compliance Solutions, a leading Pharma advisory and managed services firm.